Bedeutung der HCV-Infektion für die posttransfusionelle Hepatitis = Significance of HCV-infection for postransfusional hepatitisROGGENDORF, M.Infusionstherapie und Transfusionsmedizin. Supplement. 1994, Vol 1, pp 12-18, issn 1421-5799Article

Übertragung von Parasiten durch Bluttransfusionen und Organtransplantationen = Transmission of parasites by blood transfusion and organ transplantationBURCHARD, G.-D.Infusionstherapie und Transfusionsmedizin. Supplement. 1994, Vol 1, pp 40-48, issn 1421-5799Article

AutoimmunitySTAHL, Dorothea; SIBROWSKI, Walter.Current pharmaceutical design. 2004, Vol 10, Num 2, issn 1381-6128, 117 p.Serial Issue

Reactive Oxygen and Nitrogen Species in the Context of Autoimmune ResponsesSTAHL, Dorothea; SIBROWSKI, Walter.Current pharmaceutical design. 2004, Vol 10, Num 8, issn 1381-6128, 121 p.Serial Issue

Hepatitis B: Bedeutung für die Transfusionsmedizin = Significance of type B hepatitis for transfusion medicineJILG, W.Infusionstherapie und Transfusionsmedizin. Supplement. 1994, Vol 1, pp 20-26, issn 1421-5799Article

Übertragung von Parvovirus B19 durch Blut und Blutkomponenten = Transmission of Parvovirus B19 with blood and blood productsSCHWARZ, T. F.Infusionstherapie und Transfusionsmedizin. Supplement. 1994, Vol 1, pp 27-31, issn 1421-5799Article

Regulation of the immune response by natural IgM: Lessons from warm autoimmune hemolytic anemiaSTAHL, Dorothea; SIBROWSKI, Walter.Current pharmaceutical design. 2003, Vol 9, Num 23, pp 1871-1880, issn 1381-6128, 10 p.Article

Control of autoimmune diseases by the B7-CD28 family moleculesANAND, Sudarshan; LIEPING CHEN.Current pharmaceutical design. 2004, Vol 10, Num 2, pp 121-128, issn 1381-6128, 8 p.Article

Endothelial expression of MHC class II molecules in autoimmune diseaseTURESSON, Carl.Current pharmaceutical design. 2004, Vol 10, Num 2, pp 129-143, issn 1381-6128, 15 p.Article

Erythropoietin withdrawal leads to the destruction of young red cells at the endothelial-macrophage interfaceTRIAL, J; RICE, L.Current pharmaceutical design. 2004, Vol 10, Num 2, pp 183-190, issn 1381-6128, 8 p.Article

Diagnosis and epidemiology of transfusion-associated human cytomegalovirus infection: recent developmentsWEBER, B; DOERR, H. W.Infusionstherapie und Transfusionsmedizin. Supplement. 1994, Vol 1, pp 32-39, issn 1421-5799Article

Regulation of inflammatory responses by oxidized phospholipids: Structure-function relationshipsFURNKRANZ, A; LEITINGER, N.Current pharmaceutical design. 2004, Vol 10, Num 8, pp 915-921, issn 1381-6128, 7 p.Article

Problematik der Bakteriellen Infektion im Rahmen der Hämotherapie = Survey of bacteriae infections caused by hemotherapyBÖSENBERG, A; BÖSENBERG, E; SIBROWSKI, W et al.Infusionstherapie und Transfusionsmedizin. Supplement. 1994, Vol 1, pp 51-57, issn 1421-5799Article

The relationship between inflammation and the anticoagulant pathway: The emerging role of endothelial nitric oxide synthase (eNOS)HOOPER, W. Craig.Current pharmaceutical design. 2004, Vol 10, Num 8, pp 923-927, issn 1381-6128, 5 p.Article

Modulation of PMN-endothelial cells interactions by cyclic nucleotidesSATO, Yukio.Current pharmaceutical design. 2004, Vol 10, Num 2, pp 163-170, issn 1381-6128, 8 p.Article

Natural anticoagulant proteins in the regulation of autoimmunity: Potential role of protein SANDERSON, Howard A; SHACTER, Emily.Current pharmaceutical design. 2004, Vol 10, Num 8, pp 929-937, issn 1381-6128, 9 p.Article

Regulation of B cell activation by PECAM-1: Implications for the development of autoimmune disordersWONG, Mae-Xhum; JACKSON, Denise E.Current pharmaceutical design. 2004, Vol 10, Num 2, pp 155-161, issn 1381-6128, 7 p.Article

Complement and complement regulatory proteins as potential molecular targets for vascular diseasesACOSTA, Juan; XUEBIN QIN; HALPERIN, Jose et al.Current pharmaceutical design. 2004, Vol 10, Num 2, pp 203-211, issn 1381-6128, 9 p.Article

Transfusionsassoziierte HIV-Infektion = Transfusion-associated HIV injectionGÜRTLER, L. G; EBERLE, J; BADER, L et al.Infusionstherapie und Transfusionsmedizin. Supplement. 1994, Vol 1, pp 7-10, issn 1421-5799Article

Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: A new therapeutic approach for the treatment of inflammatory diseasesCHEN, Xi-Lin; KUNSCH, Charles.Current pharmaceutical design. 2004, Vol 10, Num 8, pp 879-891, issn 1381-6128, 13 p.Article

Inhibition of MHC II gene transcription by nitric oxide and antioxidantsHARARI, Olivier; LIAO, James K.Current pharmaceutical design. 2004, Vol 10, Num 8, pp 893-898, issn 1381-6128, 6 p.Article

Cytotoxic effects on B lymphocytes mediated by reactive oxygen speciesVILLAMOR, Neus; MONTSERRAT, Emili; COLOMER, Dolors et al.Current pharmaceutical design. 2004, Vol 10, Num 8, pp 841-853, issn 1381-6128, 13 p.Article

Endothelial chemokines in autoimmune diseaseCHRISTOPHERSON, Kent W; HROMAS, Robert A.Current pharmaceutical design. 2004, Vol 10, Num 2, pp 145-154, issn 1381-6128, 10 p.Article

B cell responses to oxidative stressTOHYAMA, Yumi; TAKANO, Tomoko; YAMAMURA, Hirohei et al.Current pharmaceutical design. 2004, Vol 10, Num 8, pp 835-839, issn 1381-6128, 5 p.Article

Functional consequences of immune cell adhesion to endothelial cellsROSEMBLATT, M; BONO, Maria Rosa.Current pharmaceutical design. 2004, Vol 10, Num 2, pp 109-120, issn 1381-6128, 12 p.Article